Posted on 7/26/18
Benchworks Launches Health System Marketing
Benchworks is pleased to announce it has launched a new division, Health System Marketing to help hospitals, health systems and providers enhance their branding and revenue . . .
Posted on 7/26/18
Tenable Prices IPO at $23.00 Per Share
Tenable Holdings, Inc. today announced the pricing of its initial public offering of 10,900,000shares of common stock at a price to the public of $23.00 per . . .
Posted on 7/25/18
Pfizer: Keep On Reinvesting Dividends
SummaryDonald Trump calls out the company on its price hikes.Shares not adversely affected.The dividend still looks strong.This idea was discussed in more depth with members of . . .
Posted on 7/25/18
Aquestive Therapeutics Prices IPO
Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced the pricing of its . . .
Posted on 7/24/18
Quest Diagnostics Reports Second Quarter 2018 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2018."Once again, . . .
Posted on 7/24/18
Pfizer & Eli Lilly Obtain Potential Pain Alternative For Treating Osteoarthritis Pain
SummaryPfizer and its partner Eli Lilly announced positive phase 3 results treating patients with osteoarthritis of the knee or hip using tanezumab.The positive phase 3 results . . .
Posted on 7/24/18
Better Buy: Gilead Sciences, Inc. vs. Celgene
Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) have both produced tremendous gains for long-term shareholders. Over a three-year period leading up to mid-2015, both of . . .
Posted on 7/24/18
Should GlaxoSmithKline Break Up?
British pharma giant GlaxoSmithKline (NYSE:GSK) is reportedly exploring a breakup of its consumer healthcare and pharma/vaccine units into separate businesses. The drugmaker's management is under pressure . . .
Posted on 7/23/18
Anima Biotech Announces an Exclusive Collaboration With Lilly
Anima Biotech today announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima's Translation Control Therapeutics . . .
Posted on 7/23/18
Sanofi Ventures Leads $17 Million Financing of Click Therapeutics
Click Therapeutics, Inc. a leader in Digital Therapeutics solutions as prescription medical treatments, announces a $17 million financing round led by Sanofi Ventures.
Posted on 7/23/18
Your Daily Pharma Scoop: Catalyst Bio Succeeds, CTI Moves Forward, Pfizer Positive
SummaryCatalyst Bio succeeds in Phase 2/3 trial.CTI plans to launch Phase 3 trial.Pfizer announces successful Phase 3 data.This idea was discussed in more depth with members . . .
Posted on 7/23/18
Better Buy: Eli Lilly and Company vs. Merck & Co.
Big pharma stocks have enjoyed investors' favor for a long time. They usually generate lots of cash that can be reinvested for growth, and that can . . .
Posted on 7/22/18
Zynerba Pharmaceuticals Prices Public Offering of Common Stock
DEVON, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) today announced the pricing of an underwritten public offering of 4,062,500 shares of its . . .
Posted on 7/19/18
Provention Bio Closes Upsized IPO
Provention Bio, Inc. (Nasdaq:PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the closing of its initial public offering of . . .
Posted on 7/19/18
Idera Pharmaceuticals Provides Update On Corporate Strategy And Outlook
EXTON, Pa., July 16, 2018 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, . . .
Posted on 7/19/18
New Partnership Between Gastrologix and Stratis Medical Offer GI Practices a Smart Choice
Gastrologix, a gastroenterology-specific GPO, is pleased to announce it has entered into an exclusive contract with Stratis Medical, Inc., one of the nation's leading distributors of . . .
Posted on 7/19/18
Why Johnson & Johnson Is An Attractive Investment
SummaryJohnson & Johnson has steadily performed during every economic cycle.The company is one of two with a AAA credit rating.The recent verdict will be appealed, even . . .
Posted on 7/19/18
Medical Guardian Wins Today’s Caregiver Magazine’s 2018 Caregiver Friendly Award
PHILADELPHIA--(BUSINESS WIRE)--Medical Guardian, the leading nationwide provider of medical alert systems for older adults, announced today that Family Guardian, an activity monitoring medical alert system, has . . .
Posted on 7/18/18
Zynerba's Therapeutics And Data Lack Conviction
SummaryThere are no FDA-approved therapies for Fragile X Syndrome.ZYN002 appears to have demonstrated meaningful and overwhelming efficacy data in a phase 2 trial.There are, however, disclaimers . . .
Posted on 7/18/18
Johnson & Johnson: Wait For The Outcome
SummaryJohnson & Johnson was handed a $4.7 billion product-liability verdict last week, the 6th largest in US history.Though company lawyers have found appellate success recently, this . . .
Posted on 7/18/18
Johnson & Johnson Looks Too Cheap
SummaryA continuation off a solid fiscal 2017; management has this blue-chip heading in the right direction.The company maintains its fortress balance sheet with its AAA S&P . . .
Posted on 7/18/18
The Wonder Of Johnson & Johnson
SummaryThe stock will ebb and flow but be in it for the dividend growth.We discuss the key takeaways from the most recent quarter, including strengths and . . .
Posted on 7/18/18
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) ranks as the world's largest healthcare company. However, the healthcare giant has been under fire somewhat so far in 2018. J&J stock . . .
Posted on 7/18/18
Johnson & Johnson (JNJ) Q2 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Johnson & Johnson (NYSE:JNJ)Q2 2018 Earnings Conference CallJuly 17, 2018, 8:30 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning and welcome to . . .
Posted on 7/18/18
What's Behind Johnson & Johnson's Double-Digit Growth?
Johnson & Johnson (NYSE:JNJ) is a healthcare giant that racks up tens of billions of dollars in revenue every quarter. Usually, it's tough to deliver double-digit . . .

